Applied Clinical Trials-09-01-2021

The Post-Pandemic CRO Landscape

September 08, 2021

Feature Articles

30

9

Technology, talent and specialization add up to a plethora of industry M&As.

Biosimilars Move to Center Stage

August 12, 2021

View from Washington

30

9

All eyes are watching closely to see how well Viatris and Biocon Biologics’ Semglee, approved by FDA on July 28, competes with Sanofi’s well-established, long-acting insulin analog, Lantus.